BPC
XBI icon

Banque Pictet & Cie’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Banque Pictet & Cie’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.52M Sell
53,821
-10,396
-16% -$1.41M 0.05% 115
2026
Q1 		$8.2M Sell
64,217
-660
-1% -$82.4K 0.06% 120
2025
Q4 		$7.91M Buy
64,877
+12,595
+24% +$1.44M 0.05% 127
2025
Q3 		$5.24M Buy
52,282
+21,239
+68% +$1.91M 0.03% 144
2025
Q2 		$2.57M Sell
31,043
-2,973
-9% -$237K 0.02% 196
2025
Q1 		$2.76M Sell
34,016
-45,814
-57% -$4.09M 0.02% 192
2024
Q4 		$7.19M Buy
79,830
+2,944
+4% +$285K 0.05% 126
2024
Q3 		$7.6M Sell
76,886
-17,940
-19% -$1.76M 0.06% 125
2024
Q2 		$8.79M Buy
94,826
+42,301
+81% +$3.79M 0.08% 104
2024
Q1 		$4.98M Sell
52,525
-44,201
-46% -$4.1M 0.05% 148
2023
Q4 		$8.64M Hold
96,726
– – 0.07% 104
2023
Q3 		$7.06M Sell
96,726
-50,000
-34% -$3.99M 0.08% 108
2023
Q2 		$12.2M Buy
146,726
+59,510
+68% +$4.98M 0.11% 98
2023
Q1 		$6.65M Buy
87,216
+2,595
+3% +$215K 0.06% 137
2022
Q4 		$7.02M Sell
84,621
-4,220
-5% -$342K 0.07% 134
2022
Q3 		$7.05M Sell
88,841
-11,790
-12% -$994K 0.08% 131
2022
Q2 		$7.47K Sell
100,631
-1,894
-2% -$142K 0.07% 125
2022
Q1 		$9.21M Buy
102,525
+80,025
+356% +$7.39M 0.07% 127
2021
Q4 		$2.52M Sell
22,500
-13,330
-37% -$1.61M 0.02% 301
2021
Q3 		$4.5M Sell
35,830
-19,480
-35% -$2.51M 0.05% 159
2021
Q2 		$7.49M Sell
55,310
-7,215
-12% -$949K 0.08% 114
2021
Q1 		$8.48M Buy
62,525
+10,005
+19% +$1.5M 0.11% 102
2020
Q4 		$7.39M Sell
52,520
-1,030
-2% -$132K 0.1% 111
2020
Q3 		$5.97M Sell
53,550
-25,000
-32% -$2.8M 0.09% 119
2020
Q2 		$8.79M Sell
78,550
-13,018
-14% -$1.28M 0.15% 81
2020
Q1 		$7.09M Buy
91,568
+15,318
+20% +$1.36M 0.15% 87
2019
Q4 		$7.25M Sell
76,250
-6,415
-8% -$555K 0.13% 107
2019
Q3 		$6.3M Sell
82,665
-900
-1% -$74.8K 0.12% 116
2019
Q2 		$7.33M Sell
83,565
-18,000
-18% -$1.54M 0.13% 98
2019
Q1 		$9.2M Sell
101,565
-40,865
-29% -$3.48M 0.18% 80
2018
Q4 		$10.2M Sell
142,430
-1,330
-0.9% -$107K 0.21% 73
2018
Q3 		$13.8M Sell
143,760
-8,420
-6% -$816K 0.26% 62
2018
Q2 		$14.5M Sell
152,180
-1,260
-0.8% -$116K 0.28% 58
2018
Q1 		$13.5M Buy
153,440
+22,875
+18% +$2.09M 0.28% 60
2017
Q4 		$11.1M Sell
130,565
-20,715
-14% -$1.74M 0.22% 67
2017
Q3 		$13.1M Buy
151,280
+14,450
+11% +$1.16M 0.3% 62
2017
Q2 		$10.6M Sell
136,830
-85,889
-39% -$6.09M 0.25% 72
2017
Q1 		$15.4M Buy
222,719
+21,799
+11% +$1.46M 0.38% 54
2016
Q4 		$11.9M Buy
200,920
+116,120
+137% +$7.17M 0.31% 65
2016
Q3 		$5.62M Sell
84,800
-71,400
-46% -$4.42M 0.14% 91
2016
Q2 		$8.45M Buy
156,200
+12,000
+8% +$657K 0.23% 70
2016
Q1 		$7.45M Buy
+144,200
New +$7.49M 0.19% 73
2014
Q2 		– Sell
-4,350
Closed -$207K – 483
2014
Q1 		$207K Buy
+4,350
New +$223K 0.01% 390

Other funds holding XBI

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Banque Pictet & Cie's XBI Position: Q2 2026 in Review

Banque Pictet & Cie reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 16% in Q2 2026, selling an estimated $1.41M and leaving 53,821 shares worth $8.52M. The position accounts for 0.05% of the portfolio, ranked #115.

Banque Pictet & Cie first reported a position in XBI in Q1 2014 and has held it in 43 quarters since. The position peaked at $15.4M in Q1 2017. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Banque Pictet & Cie held 53,821 shares of State Street SPDR S&P Biotech ETF worth $8.52M as of Q2 2026.
  • Banque Pictet & Cie sold 10,396 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.41M.
  • State Street SPDR S&P Biotech ETF made up 0.05% of Banque Pictet & Cie's portfolio in Q2 2026, its #115 holding.
  • Banque Pictet & Cie first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and has held it in 43 quarters since.
  • Banque Pictet & Cie's State Street SPDR S&P Biotech ETF position peaked at $15.4M in Q1 2017.
  • 260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.